A Study of Venetoclax and Rituximab/Hyaluronidase Human in Relapsed/Refractory CLL
Georgetown University
Georgetown University
Assistance Publique - HĂ´pitaux de Paris
Cancer Research UK
M.D. Anderson Cancer Center
Cancer Research UK
Cancer Research UK
Cancer Research UK
UNC Lineberger Comprehensive Cancer Center
Dana-Farber Cancer Institute
Baylor College of Medicine
Baylor College of Medicine
Barbara Ann Karmanos Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Case Comprehensive Cancer Center
University of Haifa
Hospices Civils de Lyon
Rutgers, The State University of New Jersey
Northwestern University
University of California, San Francisco
University of Michigan Rogel Cancer Center
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Baylor College of Medicine
Baylor College of Medicine
Mayo Clinic
Barbara Ann Karmanos Cancer Institute
University of Texas Southwestern Medical Center
University of North Carolina, Chapel Hill
Alliance for Clinical Trials in Oncology
Wake Forest University Health Sciences
Vanderbilt University Medical Center
Alliance for Clinical Trials in Oncology
Mayo Clinic
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Baylor College of Medicine
City of Hope Medical Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
Vanderbilt-Ingram Cancer Center
Memorial Sloan Kettering Cancer Center
Asan Medical Center
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
Vanderbilt-Ingram Cancer Center
Case Comprehensive Cancer Center
Mayo Clinic
Roswell Park Cancer Institute
University of California, San Francisco